Treatment of facial superficial basal cell carcinomas with imiquimod 5% cream

Clinical and Experimental Dermatology, Supplement

Volumn 28, Issue 1, 2003, Pages 16-18

  Mirza, Basit ^a   De'Ambrosis, B ^a  

^a South East Dermatology ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CASE REPORT; EDEMA; ERYTHEMA; FEMALE; HUMAN; PRIORITY JOURNAL; SIDE EFFECT; SKIN CANCER; TREATMENT OUTCOME; ULCER; FACE TUMOR; MIDDLE AGED; OINTMENT; SUNLIGHT; TOPICAL DRUG ADMINISTRATION; CLINICAL FEATURE; CREAM; HUMAN TISSUE; SKIN BIOPSY; SUPERFICIAL CANCER;

ADMINISTRATION, TOPICAL; ADULT; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; FACIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; OINTMENTS; SUNLIGHT; TREATMENT OUTCOME;

EID: 1542750213     PISSN: 09663487     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.28.s1.6.x     Document Type: Article

References (14)

1. Lacour JP. Carcinogenesis of basal cell carcinoma: genetics and molecular mechanisms. Br J Deramtol 2002; 146 (Suppl. 61): 17-9.
2. Weedon D. Tumours of the epidermis. In: Skin Pathology, 2nd edn. Sydney: Churchill Livingstone, 2002: 766.
3. Drake LA, Salasche SS, Ceilley RI et al. Guidelines of care for basal cell carcinoma. J Am Acad Dermatol 1992; 26: 117-20.
4. Nguyen TH, Ho DQ. Nonmelanoma skin cancer. Curr Treat Options Oncol 2002; 3: 193-203.
5. Edwards L, Ferenczy A, Eron L et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134: 25-30.
6. Beutner KR, Spruance SL, Hougham AJ et al. Therapeutic response of basal carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999; 41: 1002-7.
7. Drehs MM, Cook-Bolden F, Tanzi EL, Weinberg JM. Successful treatment of multiple superficial basal cell carcinoma with topical imiquimod: case report and review of the literature. Dermatol Surg 2002; 28: 427-9.
8. Hacker SM, Flowers FP. Squamous cell carcinoma of the skin. Will heightened awareness of risk factors slow its increase? Postgrad Med 1993; 93: 125-6.
9. Miller R, Birmachu W, Gerster J. Imiquimod, cytokine induction and antiviral activity. Int'l Antiviral News 1995; 3: 111-3.
10. Berman B. Imiquimod, a new immune response modifier for the treatment of external genital warts and other diseases in dermatology. Int J Dermatol 2001; 41: 7-11.
11. Strauss RM, Doyle EL, Mohsem AH, Green ST. Successful treatment of molluscum contagiosum with topical imiquimod in a severely immunocompromised HIV-positive patient. Int J STD AIDS, 2001; 12: 264-6.
12. Schroeder TL, Sengelmann RD. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream. J Am Acad Dermatol 2002; 46: 545-8.
13. Bavnick JNB. Biological treatment of basal cell carcinoma. Arch Dermatol 2000; 136: 1019-22.
14. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: S4-S7.